| 000 | 01889 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514042406.0 | ||
| 264 | 0 | _c20030220 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a1522-8002 | ||
| 024 | 7 |
_a10.1038/sj.neo.7900252 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNatarajan, Kshama | |
| 245 | 0 | 0 |
_aExposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. _h[electronic resource] |
| 260 |
_bNeoplasia (New York, N.Y.) _c |
||
| 300 |
_a409-16 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCholine _xmetabolism |
| 650 | 0 | 4 | _aCyclooxygenase 1 |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 |
_aEpithelial Cells _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycerylphosphorylcholine _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aMonomeric GTP-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aNM23 Nucleoside Diphosphate Kinases |
| 650 | 0 | 4 | _aNucleoside-Diphosphate Kinase |
| 650 | 0 | 4 |
_aPhosphorylcholine _xmetabolism |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aMori, Noriko | |
| 700 | 1 | _aArtemov, Dmitri | |
| 700 | 1 | _aBhujwalla, Zaver M | |
| 773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 4 _gno. 5 _gp. 409-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.neo.7900252 _zAvailable from publisher's website |
| 999 |
_c12074277 _d12074277 |
||